ArticleBlood advances2023

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Tassilo L A Wachsmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.